P30-EPS / Duke University, National Cancer Institute - LARVOL DELTA

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (clinicaltrials.gov) - P1 | N=24 | Active, not recruiting | Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Recruiting ➔ Active, not recruiting | N=36 ➔ 24

Enrollment change • Enrollment closed • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Malignant Glioma • Oncology • Solid Tumor • BIRC5 • MGMT

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (clinicaltrials.gov) - P1 | N=36 | Recruiting | Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Not yet recruiting ➔ Recruiting

Enrollment open • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology • Solid Tumor • BIRC5 • MGMT

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (clinicaltrials.gov) - P1 | N=36 | Not yet recruiting | Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Initiation date: Nov 2022 ➔ Feb 2023

Trial initiation date • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology • Solid Tumor • BIRC5 • MGMT

ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (clinicaltrials.gov) - P1 | N=36 | Not yet recruiting | Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP | Initiation date: Jul 2022 ➔ Nov 2022

Trial initiation date • Brain Cancer • Glioblastoma • Glioma • Oncology • Solid Tumor • BIRC5 • MGMT